Xu T, Xia S, Zhang X, Yuan Y
Inhibition of p38 MAP kinase as a therapeutic strategy
The calcitonin receptor that Cagrilintide activates seems to be involved in mood and dopamine signaling in the brain, and activation of this receptor might be behind the mood changes observed in the Cagrilintide trials
Zhu W, Feng PP, He K, Li SW, Gong JP
Safe & trusted treatments Clinic-Hours Mon & Wed 11 AM-7 PM
The regulator did not cite any issues related to the clinical safety or efficacy provided in the New Drug Application for cefepime-taniborbactam, a beta-lactam/beta-lactamase inhibitor combination antibiotic intended to treat adults with complicated urinary tract infections